Medicare’s $2,100 Drug Quietly Reshapes Prescription Costs for Investors
Medicare's out-of-pocket cap for covered prescriptions rises to $2,100 in 2026, ending the donut-hole-era for many pa...
Explore why price weighting influences benchmark performance and how to account for it in analysis and comparisons.
26,632 articlesMedicare's out-of-pocket cap for covered prescriptions rises to $2,100 in 2026, ending the donut-hole-era for many pa...
Applied Optoelectronics falls 12% as AI optics trade cools, with peers Lumentum and Coherent also lower. Analysts cit...
NVIDIA delivered a robust quarterly report, yet its shares failed to spark a lasting breakout. Investors want clearer...
CEOs are shifting from a single forecast to multi-scenario, wartime-style planning to weather shocks. CFOs play a piv...
Pangaea (PANL) 2026 earnings narrative hinges on revenue growth, margin expansion, and cash flow strength. This guide...
Palantir has been in the AI spotlight, but its stock has traded volatile. This guide helps you separate hype from fun...
A new AI chip announcement from Nvidia sparked a powerful rally in Arm Holdings. This guide breaks down the catalysts...
In morning trading, Tesla sinks about 5% while Lucid edges higher and Rivian drifts, signaling a diverging path for t...
The price gap between gasoline and crude has widened, causing gasoline prices rising faster than oil at the pump even...
As Baidu surges, a hedge fund’s multi-million bet raises questions about AI, China’s digital economy, and portfolio c...
In a real-time test, we asked AI to pick the best crypto among Bitcoin, XRP, and Solana. The AI ranked Solana first, ...
Beyond Meat's stock has faced a steep slide, but the plant-based meat story isn’t closed. This guide breaks down the ...